Inhibidores de la isocitrato deshidrogenasa mutata (mIDH), ivosidenib o enasidenib, en combinación con azacitidina (AZA) en pacientes con leucemia mieloide aguda (LMA) Meeting Abstract

  


Authors: Montesinos, P.; Di Nardo, C. D.; Stein, A. S.; Stein, E. M.; Fathi, A. T.; Schuh, A. C.; Odenike, O.; Kantarjian, H. M.; Stone, R. M.; Collins, R.; Martinelli, G.; Arnan, M.; Wu, B.; Zhang, V.; Gong, J.; MacBeth, K. J.; Vyas, P.
Abstract Title: Inhibidores de la isocitrato deshidrogenasa mutata (mIDH), ivosidenib o enasidenib, en combinación con azacitidina (AZA) en pacientes con leucemia mieloide aguda (LMA)
Meeting Title: 60th National Congress of the Spanish Society of Hematology and Hemotherapy
Journal Title: Haematologica
Volume: 103
Issue: Suppl. 2
Meeting Dates: 2018 Oct 11-13
Meeting Location: Granada, Spain
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2018-10-01
Start Page: 25
End Page: 26
Language: Spanish
ACCESSION: WOS:000451724600037
PROVIDER: wos
Notes: Meeting Abstract: CO-030 -- "Inhibitors of the mutated dehydrogenase (MIDH), ivosidenib or enasidenib, in combination with azacitine (AZA) in patients with acute myeloid leukemia (AML)" -- Source: Wos